Exome Sequencing in an ADSHE Family: VUS Identification and Limits

Int J Environ Res Public Health. 2022 Oct 1;19(19):12548. doi: 10.3390/ijerph191912548.

Abstract

Autosomal dominant sleep-related hypermotor epilepsy (ADSHE) is the familial form of a focal epilepsy characterized by hyperkinetic focal seizures, mainly arising during non-rapid eye movements (NREM) sleep. Mutations associated with ADSHE account for a small proportion of the genetically determined cases, suggesting the existence of other disease-causing genes. Here, we reported the results obtained by performing trio-based whole-exome sequencing (WES) in an Italian family showing ADSHE and investigated the structural impact of putative variants by in silico modeling analysis. We identified a p.(Trp276Gly) variant in MOXD1 gene encoding the monooxigenase DBH like 1 protein, cosegregating with the disease and annotated as VUS under the ACMG recommendations. Structural bioinformatic analysis predicted a high destabilizing effect of this variant, due to the loss of important hydrophilic bonds and an expansion of cavity volume in the protein hydrophobic core. Although our data support a functional effect of the p.(Trp276Gly) variant, we highlight the need to identify additional families carrying MOXD1 mutations or functional analyses in suitable models to clarify its role in ADSHE pathogenesis. Moreover, we discuss the importance of VUS reporting due to the low rate of pathogenic variant identification by NGS in epilepsy and for future reinterpretation studies.

Keywords: ADSHE; epilepsy; gene; mutation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epilepsy*
  • Exome Sequencing / methods
  • Exome*
  • Humans
  • Mutation
  • Pedigree

Grants and funding

This research was funded by the University of Milano-Bicocca, grant numbers 2020-ATE-0019 and 2021-ATE-0266.